SUPN logo

Supernus Pharmaceuticals (SUPN) Long term debt

Annual long term debt:

$27.38M-$5.81M(-17.51%)
December 31, 2024

Summary

  • As of today (May 29, 2025), SUPN annual long term debt is $27.38 million, with the most recent change of -$5.81 million (-17.51%) on December 31, 2024.
  • During the last 3 years, SUPN annual long term debt has fallen by -$393.17 million (-93.49%).
  • SUPN annual long term debt is now -93.49% below its all-time high of $420.55 million, reached on December 31, 2021.

Performance

SUPN Long term debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSUPNbalance sheet metrics

Quarterly long term debt:

$26.37M-$1.01M(-3.70%)
March 31, 2025

Summary

  • As of today (May 29, 2025), SUPN quarterly long term debt is $26.37 million, with the most recent change of -$1.01 million (-3.70%) on March 31, 2025.
  • Over the past year, SUPN quarterly long term debt has dropped by -$6.63 million (-20.08%).
  • SUPN quarterly long term debt is now -94.01% below its all-time high of $440.27 million, reached on March 31, 2022.

Performance

SUPN Quarterly long term debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSUPNbalance sheet metrics

Long term debt Formula

Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt

SUPN Long term debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-17.5%-20.1%
3 y3 years-93.5%-94.0%
5 y5 years-92.7%-93.1%

SUPN Long term debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-93.5%at low-94.0%at low
5 y5-year-93.5%at low-94.0%at low
alltimeall time-93.5%+557.4%-94.0%+1691.3%

SUPN Long term debt History

DateAnnualQuarterly
Mar 2025
-
$26.37M(-3.7%)
Dec 2024
$27.38M(-17.5%)
$27.38M(-5.3%)
Sep 2024
-
$28.93M(-4.5%)
Jun 2024
-
$30.29M(-8.2%)
Mar 2024
-
$32.99M(-0.6%)
Dec 2023
$33.20M(-7.8%)
$33.20M(-1.9%)
Sep 2023
-
$33.84M(-1.0%)
Jun 2023
-
$34.18M(-6.4%)
Mar 2023
-
$36.51M(+1.4%)
Dec 2022
$36.00M(-91.4%)
$36.00M(-0.1%)
Sep 2022
-
$36.03M(-2.8%)
Jun 2022
-
$37.08M(-91.6%)
Mar 2022
-
$440.27M(+4.7%)
Dec 2021
$420.55M(+2.4%)
$420.55M(+2.1%)
Sep 2021
-
$412.05M(+1.4%)
Jun 2021
-
$406.53M(-1.6%)
Mar 2021
-
$413.07M(+0.6%)
Dec 2020
$410.56M(+9.3%)
$410.56M(+1.0%)
Sep 2020
-
$406.33M(+1.1%)
Jun 2020
-
$401.84M(+5.7%)
Mar 2020
-
$380.04M(+1.2%)
Dec 2019
$375.61M(+14.0%)
$375.61M(+2.0%)
Sep 2019
-
$368.42M(+1.0%)
Jun 2019
-
$364.75M(+1.0%)
Mar 2019
-
$361.13M(+9.6%)
Dec 2018
$329.46M
$329.46M(+1.2%)
Sep 2018
-
$325.67M(+1.2%)
Jun 2018
-
$321.92M(+1.2%)
DateAnnualQuarterly
Mar 2018
-
$318.23M(>+9900.0%)
Jun 2017
-
$1.47M(-55.5%)
Mar 2017
-
$3.31M(-20.5%)
Dec 2016
$4.17M(-41.2%)
$4.17M(-27.8%)
Sep 2016
-
$5.77M(+1.3%)
Jun 2016
-
$5.70M(+1.3%)
Mar 2016
-
$5.63M(-20.6%)
Dec 2015
$7.08M(-73.0%)
$7.08M(-12.2%)
Sep 2015
-
$8.07M(-7.9%)
Jun 2015
-
$8.76M(-25.2%)
Mar 2015
-
$11.71M(-55.4%)
Dec 2014
$26.22M(-23.8%)
$26.22M(-1.0%)
Sep 2014
-
$26.50M(-7.6%)
Jun 2014
-
$28.67M(+1.1%)
Mar 2014
-
$28.36M(-17.5%)
Dec 2013
$34.39M(+210.2%)
$34.39M(-42.8%)
Sep 2013
-
$60.17M(+1.8%)
Jun 2013
-
$59.10M(+641.1%)
Mar 2013
-
$7.97M(-28.1%)
Dec 2012
$11.09M(-51.2%)
$11.09M(-21.5%)
Sep 2012
-
$14.12M(-17.3%)
Jun 2012
-
$17.06M(-14.4%)
Mar 2012
-
$19.93M(-12.3%)
Dec 2011
$22.71M(-69.7%)
$22.71M(-73.6%)
Sep 2011
-
$86.01M(+14.7%)
Sep 2010
-
$75.00M(0.0%)
Dec 2009
$75.00M(0.0%)
$75.00M
Dec 2008
$75.00M
-

FAQ

  • What is Supernus Pharmaceuticals annual long term debt?
  • What is the all time high annual long term debt for Supernus Pharmaceuticals?
  • What is Supernus Pharmaceuticals annual long term debt year-on-year change?
  • What is Supernus Pharmaceuticals quarterly long term debt?
  • What is the all time high quarterly long term debt for Supernus Pharmaceuticals?
  • What is Supernus Pharmaceuticals quarterly long term debt year-on-year change?

What is Supernus Pharmaceuticals annual long term debt?

The current annual long term debt of SUPN is $27.38M

What is the all time high annual long term debt for Supernus Pharmaceuticals?

Supernus Pharmaceuticals all-time high annual long term debt is $420.55M

What is Supernus Pharmaceuticals annual long term debt year-on-year change?

Over the past year, SUPN annual long term debt has changed by -$5.81M (-17.51%)

What is Supernus Pharmaceuticals quarterly long term debt?

The current quarterly long term debt of SUPN is $26.37M

What is the all time high quarterly long term debt for Supernus Pharmaceuticals?

Supernus Pharmaceuticals all-time high quarterly long term debt is $440.27M

What is Supernus Pharmaceuticals quarterly long term debt year-on-year change?

Over the past year, SUPN quarterly long term debt has changed by -$6.63M (-20.08%)
On this page